-
Forward Look
Targeted Therapy Prompts Responses in KRAS-mutated Lung CancerAn experimental KRAS inhibitor controls lung cancer after other targeted treatments stop working.
by Eric Fitzsimmons
-
Wearable Devices Help Monitor Patient Health After Cancer TreatmentResearchers evaluate whether devices that track health metrics like daily steps and heart rate can help predict clinical outcomes.
by Darlene Dobkowski
-
Safely Extending Treatment in Alveolar Soft Part SarcomaPeople with the soft tissue cancer can receive immunotherapy for an extended period without long-term side effects.
by Thomas Celona
-
The Week in Cancer News: Targeting Pancreatic Cancer and When to Give CDK4/6 InhibitorsResults show targeted therapies’ potential to extend pancreatic cancer survival, and CDK4/6 inhibitors in breast cancer come with fewer side effects when given later.
by Marci A. Landsmann
-
Maintaining Platelet Counts During ChemotherapyA platelet-stimulating drug may reduce bleeding risk and help patients continue regular doses of their cancer treatment.
by Brianna Abbott
-
Reducing Hot Flashes in Men With Prostate CancerA drug commonly used for overactive bladder helps reduce hot flashes in men receiving hormone therapy.
by Kyle Bagenstose
-
The Week in Cancer News: Treatment-related Blood Cancers and Lower Cancer Rates Among Married PeopleRates of treatment-related leukemia rise as more people survive cancer, and cancer rates are higher in people who have never been married.
by Eric Fitzsimmons
-
Food Safety for Blood Cancer Patients With Low White Blood CellsA neutropenic diet reduces infection risk after stem cell transplant or induction chemotherapy.
by Cameron Walker
-
AI Empowers Patients to Navigate Cancer CareAACR patient advocate forum describes how AI tools can help advance research and educate patients.
by Darlene Dobkowski
-
The Week in Cancer News: Vaping Risks and Tailoring Radiation in Breast CancerNicotine-based e-cigarettes likely increase risk for oral and lung cancers, and adjusting radiation after chemotherapy preserves low breast cancer recurrence rates.
by Darlene Dobkowski
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
